CoChat

A biallelic variant of the RNA exosome gene, EXOSC4, associated with neurodevelopmental defects impairs RNA exosome function and translation

Open access

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index; none of the 41 sources its claims cite is checked for support yet.

Abstract

The RNA exosome is an evolutionarily conserved complex required for both precise RNA processing and decay. Pathogenic variants in EXOSC genes, which encode structural subunits of this complex, are linked to several autosomal recessive disorders. Here, we describe a missense allele of the EXOSC4 gene that causes a collection of clinical features in two affected siblings. This missense variant (NM_019037.3: exon3:c.560T>C) changes a leucine residue within a conserved region of EXOSC4 to proline (p.Leu187Pro). The two affected individuals show prenatal growth restriction, failure to thrive, global developmental delay, intracerebral and basal ganglia calcifications, and kidney failure. Homozygosity for the damaging variant was identified by exome sequencing with Sanger sequencing to confirm segregation. To explore the functional consequences of this amino acid change, we modeled EXOSC4-L187P in the corresponding budding yeast protein, Rrp41 (Rrp41-L187P). Cells that express Rrp41-L187P as the sole copy of the essential Rrp41 protein show growth defects. Steady-state levels of both Rrp41-L187P and EXOSC4-L187P are decreased compared to controls, and EXOSC4-L187P shows decreased copurification with other RNA exosome subunits. RNA exosome target transcripts accumulate in rrp41-L187P cells, including the 7S precursor of 5.8S rRNA. Polysome profiles show a decrease in actively translating ribosomes in rrp41-L187P cells as compared to control cells with the incorporation of 7S pre-rRNA into polysomes. This work adds EXOSC4 to the structural subunits of the RNA exosome that have been linked to human disease and defines foundational molecular defects that could contribute to the adverse phenotypes caused by EXOSC pathogenic variants.

Overview

CoChat Summary

TL;DR

This paper identifies a homozygous EXOSC4 p.Leu187Pro variant in two siblings with neurodevelopmental defects and models it in yeast and mouse cells, showing impaired RNA exosome function and translation. The variant decreases EXOSC4/Rrp41 protein levels and interactions with other exosome subunits, causing target RNA accumulation, rRNA processing defects, and reduced polysomes.

Key findings

  • Two affected siblings from a consanguineous Omani family were homozygous for EXOSC4 NM_019037.3:c.560T>C (p.Leu187Pro); clinical features included prenatal growth restriction, failure to thrive, global developmental delay, intracerebral and basal ganglia calcifications, and kidney failure. The variant was absent from public databases and predicted damaging by multiple in silico tools.
  • Yeast cells expressing Rrp41-L187P as the sole essential Rrp41 copy showed growth defects at 25, 30, and 37 °C (virtually no growth at 37 °C, severe impairment at 30 °C, mild defect at 25 °C); Rrp41-L187P protein levels were decreased to 56% of control at 30 °C and 32% at 37 °C, and RNA exosome target transcripts U4 pre-snRNA, TLC1 pre-ncRNA, and U14 snoRNA accumulated 9–20-fold.
  • rrp41-L187P cells showed rRNA processing defects with accumulation of 33S, 27S, 23S, and 7S pre-rRNA and decreased 20S, 18S, 25S, and 5.8S rRNA; polysome profiles showed reduced polysomes, and 7S pre-rRNA was found in polysomes in 11–26% of mutant cells versus 0–4% of WT cells.
  • In mouse Neuro2A cells, Myc-EXOSC4-L187P was decreased to ∼40% of WT EXOSC4 and showed drastically reduced copurification with EXOSC8, EXOSC9, and EXOSC10; increasing Rrp41-L187P levels improved growth and reduced target transcripts but did not fully restore WT function.

Methods

  • Clinical genetics: trio whole-exome sequencing of two affected siblings and the unaffected father, with Sanger sequencing to confirm segregation; variant filtering used public databases and an in-house database of 1564 exomes.
  • Yeast modeling: S. cerevisiae rrp41-L187P strains were generated by plasmid shuffle and CRISPR-Cas9 genome editing; assays included growth tests, immunoblotting, RT-qPCR for exosome target transcripts, northern blotting for rRNA processing, and polysome profiling with cycloheximide or puromycin treatment.
  • Mammalian and structural work: mouse Neuro2A cells were transfected with Myc-EXOSC4 or Myc-EXOSC4-L187P for immunoblotting and co-immunoprecipitation of exosome subunits; structural analysis used PDB 6D6R and 6FSZ with PyMOL and AlphaFold.

Limitations

  • Stated: in the mammalian experiments, cells expressed both WT EXOSC4 and exogenous Myc-tagged EXOSC4; the authors note that future experiments using cells engineered to express EXOSC4-L187P as the sole copy would be valuable. They also state that further studies are needed to determine whether yeast polysome changes extend to patient cells or mammalian disease models and how these changes alter the proteome.
  • Evident from the text: the clinical evidence is limited to two affected siblings, and no patient-derived cell or tissue functional validation is reported; the functional mechanism is inferred largely from a budding yeast model and overexpression in a mouse neuronal cell line.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.jbc.2024.107571

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Identification of an EXOSC4 variant.A, pedigree of the Omani family with two affected offspring. Shaded symbols indicate affected individuals. The genotype is shown for those individuals who were analyzed. All genotypic carrier individuals are phenotypically healthy. B, axial CT brain scan for the affected individual III-1 at the age of 16 years shows bilateral diffuse calcification of the basal ganglia, including the caudate nucleus along with subcortical calcification of both parietal lobes at the centrum semiovale level. C, chromatograms for the Sanger sequencing showing the sequencing for patient (III-1), control, parent (II-1), and unaffected sibling (III-2). The sequencing identified the EXOSC4 variant (NM_019037.3:c.560T>C (p.Leu187Pro)). The nucleotide sequence variant is indicated on top with the change in amino acid sequence indicated on the bottom.
Figure 1 Identification of an EXOSC4 variant.A, pedigree of the Omani family with two affected offspring. Shaded symbols indicate affected individuals. The genotype is shown for those individuals who were analyzed. All genotypic carrier individuals are phenotypically healthy. B, axial CT brain scan for the affected individual III-1 at the age of 16 years shows bilateral diffuse calcification of the basal ganglia, including the caudate nucleus along with subcortical calcification of both parietal lobes at the centrum semiovale level. C, chromatograms for the Sanger sequencing showing the sequencing for patient (III-1), control, parent (II-1), and unaffected sibling (III-2). The sequencing identified the EXOSC4 variant (NM_019037.3:c.560T>C (p.Leu187Pro)). The nucleotide sequence variant is indicated on top with the change in amino acid sequence indicated on the bottom.CC BY · PubMed Central
Figure 2 Conservation and location of the Leu187 residue in the EXOSC4/Rrp41 subunit of the RNA exosome that is altered in disease.A, a cartoon model of the 10-subunit RNA exosome complex is shown. The subunits of the complex are indicated by their EXOSC number (1–3 in the cap, 4–9 in the barrel-like core ring), with the catalytic DIS3 subunit at the base. EXOSC4 (Rrp41 in budding yeast), which is a component of the barrel-shaped core ring structure, is highlighted in teal and the proximal subunit EXOSC9 (Rrp45 in budding yeast) is highlighted in slate blue. B, schematic of domain organization of EXOSC4. EXOSC4 is composed of a single RNase PH-like domain. Alignment of EXOSC4/Rrp41 amino acid sequences from Homo sapiens (H.s.), Mus musculus (M.m.), Drosophila melanogaster (D.m.), and Saccharomyces cerevisiae (S.c.) below the schematic show the conservation of the Leu187 residue (magenta). C, structural model of the human RNA exosome complex (PDB: 6D6R) (27) and (D) budding yeast RNA exosome complex (PDB: 6FSZ) (30). The zoomed in boxes in (C and D) depict the RNA exosome subunits EXOSC4/Rrp41 (teal) and EXOSC9/Rrp45 (slate blue) that share an interface and show the location of the Leu187 residue (magenta) in EXOSC4/Rrp41. The EXOSC4/Rrp41 residue Leu199 (teal) and the EXOSC9 residue Ile234/Rrp45 residue Val248 (slate blue) in close contact with the EXOSC4/Rrp41 residue Leu187 are shown.
Figure 2 Conservation and location of the Leu187 residue in the EXOSC4/Rrp41 subunit of the RNA exosome that is altered in disease.A, a cartoon model of the 10-subunit RNA exosome complex is shown. The subunits of the complex are indicated by their EXOSC number (1–3 in the cap, 4–9 in the barrel-like core ring), with the catalytic DIS3 subunit at the base. EXOSC4 (Rrp41 in budding yeast), which is a component of the barrel-shaped core ring structure, is highlighted in teal and the proximal subunit EXOSC9 (Rrp45 in budding yeast) is highlighted in slate blue. B, schematic of domain organization of EXOSC4. EXOSC4 is composed of a single RNase PH-like domain. Alignment of EXOSC4/Rrp41 amino acid sequences from Homo sapiens (H.s.), Mus musculus (M.m.), Drosophila melanogaster (D.m.), and Saccharomyces cerevisiae (S.c.) below the schematic show the conservation of the Leu187 residue (magenta). C, structural model of the human RNA exosome complex (PDB: 6D6R) (27) and (D) budding yeast RNA exosome complex (PDB: 6FSZ) (30). The zoomed in boxes in (C and D) depict the RNA exosome subunits EXOSC4/Rrp41 (teal) and EXOSC9/Rrp45 (slate blue) that share an interface and show the location of the Leu187 residue (magenta) in EXOSC4/Rrp41. The EXOSC4/Rrp41 residue Leu199 (teal) and the EXOSC9 residue Ile234/Rrp45 residue Val248 (slate blue) in close contact with the EXOSC4/Rrp41 residue Leu187 are shown.CC BY · PubMed Central
Figure 3 The budding yeast rrp41-L187P mutant shows impaired growth, reduced Rrp41 protein level, and elevated levels of RNA exosome target transcripts.A, rrp41-L187P mutant cells show impaired growth at all temperatures (25, 30, 37 °C) tested. In the upper panel, the rrp41Δ cells containing RRP41 or rrp41-L187P plasmid were serially diluted, spotted, and grown at the indicated temperatures for 2 to 3 days. In the lower panel, two rrp41-L187P CRISPR mutant strains (1 & 2) containing Vector or RRP41 plasmid and a WT control were serially diluted, spotted, and grown at the indicated temperatures for 2 to 3 days. B, the steady-state level of the Rrp41-L187P protein variant is significantly decreased at 30 °C and 37 °C. Lysates of rrp41Δ cells solely expressing Myc-tagged, WT Rrp41, or Rrp41-L187P grown at 30 °C or 37 °C were analyzed by immunoblotting with an anti-Myc antibody to detect Rrp41-Myc and an anti-Pgk1 antibody to detect 3-phosphoglycerate kinase (Pgk1) as a loading control. The stain-free signal on the immunoblot is also shown as a loading control. C, quantitation of the relative level of Rrp41-L187P protein compared to Rrp41 detected in the lysates of rrp41Δ cells solely expressing Myc-tagged Rrp41 or Rrp41-L187P grown at 30 °C or 37 °C from three independent experiments – one shown in B. Graph shows the relative level of Rrp41-L187P-Myc protein compared to WT Rrp41-Myc, which is set to 1.0 (n = 3). Error bars represent SEM. Statistical significance is calculated by a Student’s t test (∗p-value ≤ 0.05; ∗∗ p-value ≤ 0.01). D–F, rrp41-L187P cells show elevated, steady-state levels of (D) U4 pre-snRNA, (E) TLC1 telomerase component pre-ncRNA, and (F) U14 snoRNA relative to RRP41 cells at 37 °C. Total RNA was isolated from rrp41Δ cells solely expressing RRP41 or rrp41-L187P grown at 37 °C, and transcript levels were measured by RT-qPCR using gene-specific primers (illustrated above each graph), normalized relative to RRP41. Error bars represent SEM from three biological replicates. Statistical significance of the RNA levels in rrp41-L187P cells relative to RRP41 cells was calculated by Student’s t test (∗∗∗p-value ≤ 0.001; ∗∗∗∗p-value ≤ 0.0001).
Figure 3 The budding yeast rrp41-L187P mutant shows impaired growth, reduced Rrp41 protein level, and elevated levels of RNA exosome target transcripts.A, rrp41-L187P mutant cells show impaired growth at all temperatures (25, 30, 37 °C) tested. In the upper panel, the rrp41Δ cells containing RRP41 or rrp41-L187P plasmid were serially diluted, spotted, and grown at the indicated temperatures for 2 to 3 days. In the lower panel, two rrp41-L187P CRISPR mutant strains (1 & 2) containing Vector or RRP41 plasmid and a WT control were serially diluted, spotted, and grown at the indicated temperatures for 2 to 3 days. B, the steady-state level of the Rrp41-L187P protein variant is significantly decreased at 30 °C and 37 °C. Lysates of rrp41Δ cells solely expressing Myc-tagged, WT Rrp41, or Rrp41-L187P grown at 30 °C or 37 °C were analyzed by immunoblotting with an anti-Myc antibody to detect Rrp41-Myc and an anti-Pgk1 antibody to detect 3-phosphoglycerate kinase (Pgk1) as a loading control. The stain-free signal on the immunoblot is also shown as a loading control. C, quantitation of the relative level of Rrp41-L187P protein compared to Rrp41 detected in the lysates of rrp41Δ cells solely expressing Myc-tagged Rrp41 or Rrp41-L187P grown at 30 °C or 37 °C from three independent experiments – one shown in B. Graph shows the relative level of Rrp41-L187P-Myc protein compared to WT Rrp41-Myc, which is set to 1.0 (n = 3). Error bars represent SEM. Statistical significance is calculated by a Student’s t test (∗p-value ≤ 0.05; ∗∗ p-value ≤ 0.01). D–F, rrp41-L187P cells show elevated, steady-state levels of (D) U4 pre-snRNA, (E) TLC1 telomerase component pre-ncRNA, and (F) U14 snoRNA relative to RRP41 cells at 37 °C. Total RNA was isolated from rrp41Δ cells solely expressing RRP41 or rrp41-L187P grown at 37 °C, and transcript levels were measured by RT-qPCR using gene-specific primers (illustrated above each graph), normalized relative to RRP41. Error bars represent SEM from three biological replicates. Statistical significance of the RNA levels in rrp41-L187P cells relative to RRP41 cells was calculated by Student’s t test (∗∗∗p-value ≤ 0.001; ∗∗∗∗p-value ≤ 0.0001).CC BY · PubMed Central
Figure 4 Increasing the level of the Rrp41-L187P protein improves RNA exosome function but not to the same level as WT Rrp41. Myc-tagged Rrp41 or Rrp41-L187P (A and B) or untagged Rrp41 or Rrp41-L187P (C–E) was expressed from either a low copy (CEN) or high copy (2μ) plasmid in rrp41Δ cells as the sole source of Rrp41 in the cells. A, as assessed by immunoblotting with an anti-Myc antibody, steady-state levels of both Rrp41-Myc and Rrp41-L187P-Myc are significantly increased from the high copy (2μ) plasmid compared to the low copy (CEN) plasmid. Samples were probed with anti-Pgk1 antibody to detect Pgk1 as a loading control. The stain-free signal on the immunoblot is also shown as a loading control. B, to quantitate the fold-change in levels of Rrp41 and Rrp41-L187P from high copy versus low copy plasmids, the level of high copy (2μ) Rrp41 or Rrp41-L187P was normalized to low copy (CEN) Rrp41 or Rrp41-L187P, respectively. Rrp41 protein expressed from the low copy (CEN) plasmid was therefore set to 1.0. As shown in the bar graphs, for results at 30 °C (top) and 37 °C (bottom), the levels of Rrp41 are increased 16.3-fold while levels of Rrp41-L187P are increased 14.3-fold for the high copy (2μ) plasmid versus the low copy (CEN) plasmid at 30 °C. Levels of Rrp41 are increased 6.5-fold while levels of Rrp41-L187P are increased 25.8-fold from the high copy (2μ) plasmid versus the low copy (CEN) plasmid at 37 °C. Error bars represent SEM. Statistical significance is calculated by a Student’s t test (∗p-value ≤ 0.05). C, the rrp41Δ cells expressing Rrp41-L187P from the high copy (2μ) plasmid show improved growth compared to cells expressing Rrp41-L187P from the low copy (CEN) plasmid at 25 °C and 30 °C. The rrp41Δ cells containing RRP41 or rrp41-L187P low copy or high copy plasmid were serially diluted, spotted, and grown at the indicated temperatures for 2 to 3 days. D and E, the steady-state levels of RNA exosome target transcripts (D) U4 pre-snRNA and (E) TLC1 telomerase component pre-ncRNA exhibit a statistically significant decrease in rrp41Δ cells expressing Rrp41-L187P from the high copy (2μ) plasmid compared to cells expressing Rrp41-L187P from the low copy (CEN) plasmid. Total RNA was isolated from rrp41Δ cells expressing either low copy (CEN) or high copy (2μ) RRP41 or rrp41-L187P plasmid grown at 30 °C, and transcript levels were measured by RT-qPCR using gene-specific primers (illustrated above each graph), normalized relative to the low copy (CEN) RRP41 sample, which was set to 1.0. Error bars represent SEM from three biological replicates. Statistical significance was calculated by a Student’s t test (∗∗p-value ≤ 0.01; ∗∗∗p-value ≤ 0.001).
Figure 4 Increasing the level of the Rrp41-L187P protein improves RNA exosome function but not to the same level as WT Rrp41. Myc-tagged Rrp41 or Rrp41-L187P (A and B) or untagged Rrp41 or Rrp41-L187P (C–E) was expressed from either a low copy (CEN) or high copy (2μ) plasmid in rrp41Δ cells as the sole source of Rrp41 in the cells. A, as assessed by immunoblotting with an anti-Myc antibody, steady-state levels of both Rrp41-Myc and Rrp41-L187P-Myc are significantly increased from the high copy (2μ) plasmid compared to the low copy (CEN) plasmid. Samples were probed with anti-Pgk1 antibody to detect Pgk1 as a loading control. The stain-free signal on the immunoblot is also shown as a loading control. B, to quantitate the fold-change in levels of Rrp41 and Rrp41-L187P from high copy versus low copy plasmids, the level of high copy (2μ) Rrp41 or Rrp41-L187P was normalized to low copy (CEN) Rrp41 or Rrp41-L187P, respectively. Rrp41 protein expressed from the low copy (CEN) plasmid was therefore set to 1.0. As shown in the bar graphs, for results at 30 °C (top) and 37 °C (bottom), the levels of Rrp41 are increased 16.3-fold while levels of Rrp41-L187P are increased 14.3-fold for the high copy (2μ) plasmid versus the low copy (CEN) plasmid at 30 °C. Levels of Rrp41 are increased 6.5-fold while levels of Rrp41-L187P are increased 25.8-fold from the high copy (2μ) plasmid versus the low copy (CEN) plasmid at 37 °C. Error bars represent SEM. Statistical significance is calculated by a Student’s t test (∗p-value ≤ 0.05). C, the rrp41Δ cells expressing Rrp41-L187P from the high copy (2μ) plasmid show improved growth compared to cells expressing Rrp41-L187P from the low copy (CEN) plasmid at 25 °C and 30 °C. The rrp41Δ cells containing RRP41 or rrp41-L187P low copy or high copy plasmid were serially diluted, spotted, and grown at the indicated temperatures for 2 to 3 days. D and E, the steady-state levels of RNA exosome target transcripts (D) U4 pre-snRNA and (E) TLC1 telomerase component pre-ncRNA exhibit a statistically significant decrease in rrp41Δ cells expressing Rrp41-L187P from the high copy (2μ) plasmid compared to cells expressing Rrp41-L187P from the low copy (CEN) plasmid. Total RNA was isolated from rrp41Δ cells expressing either low copy (CEN) or high copy (2μ) RRP41 or rrp41-L187P plasmid grown at 30 °C, and transcript levels were measured by RT-qPCR using gene-specific primers (illustrated above each graph), normalized relative to the low copy (CEN) RRP41 sample, which was set to 1.0. Error bars represent SEM from three biological replicates. Statistical significance was calculated by a Student’s t test (∗∗p-value ≤ 0.01; ∗∗∗p-value ≤ 0.001).CC BY · PubMed Central
Figure 5 The rrp41-L187P cells exhibit defects in rRNA processing. A, schematic of yeast 35S rRNA indicating the locations of rRNA cleavage sites and northern blot probes used (P1-P6; red). The 35S rRNA transcript contains 18S, 5.8S, and 25S rRNA separated by internal transcribed spacer 1 and 2 (ITS1, ITS2) and flanked by 5′ and 3′ external transcribed spacer (5′ETS, 3′ETS). B, northern blotting of three independent biological replicates of rrp41-L187P CRISPR mutant and WT (RRP41) cells reveals rRNA processing defects in rrp41-L187P mutant cells, including the accumulation of 7S pre-rRNA. Equal amounts of total RNA from control WT RRP41 cells or rrp41-L187P cells grown at 30 °C was used for northern blotting. The 5S probe was used a loading control.
Figure 5 The rrp41-L187P cells exhibit defects in rRNA processing. A, schematic of yeast 35S rRNA indicating the locations of rRNA cleavage sites and northern blot probes used (P1-P6; red). The 35S rRNA transcript contains 18S, 5.8S, and 25S rRNA separated by internal transcribed spacer 1 and 2 (ITS1, ITS2) and flanked by 5′ and 3′ external transcribed spacer (5′ETS, 3′ETS). B, northern blotting of three independent biological replicates of rrp41-L187P CRISPR mutant and WT (RRP41) cells reveals rRNA processing defects in rrp41-L187P mutant cells, including the accumulation of 7S pre-rRNA. Equal amounts of total RNA from control WT RRP41 cells or rrp41-L187P cells grown at 30 °C was used for northern blotting. The 5S probe was used a loading control.CC BY · PubMed Central
Figure 6 The rrp41-L187P cells show altered polysome profiles. A, polysome profiling reveals that rrp41-L187P CRISPR mutant cells show a loss of polysomes at 30 °C as compared to WT RRP41 cells. Clarified cell extracts of rrp41-L187P CRISPR mutant cells and WT RRP41 cells were resolved on a 10 to 50% sucrose gradient and scanned at 260 nm. The fraction numbers are indicated and peaks corresponding to the small (40S) and large (60S) ribosome subunits, as well as the monosomes (80S) and polysomes are marked. B, northern blotting on fractions from sucrose gradients treated with cycloheximide reveal the distribution of 5.8S rRNA and 7S pre-rRNA. The fraction of 7S rRNA present in polysomes was quantitated as described in Experimental procedures. C, to confirm that rRNA species detected by northern blotting in polysomes are not aggregates or other large complexes, samples were treated with puromycin prior to loading on the sucrose gradient and (D) fractions from these gradients were analyzed by northern blotting as described for (B). The fraction of 7S pre-rRNA migrating in polysomes versus total 7S pre-rRNA was quantified using data from three biological replicates for samples treated with cycloheximide (E) and two independent biological replicates for lysates treated with puromycin (F). Error bars represent SEM from biological replicates. Statistical significance was calculated by Student’s t test (∗p-value <0.05).
Figure 6 The rrp41-L187P cells show altered polysome profiles. A, polysome profiling reveals that rrp41-L187P CRISPR mutant cells show a loss of polysomes at 30 °C as compared to WT RRP41 cells. Clarified cell extracts of rrp41-L187P CRISPR mutant cells and WT RRP41 cells were resolved on a 10 to 50% sucrose gradient and scanned at 260 nm. The fraction numbers are indicated and peaks corresponding to the small (40S) and large (60S) ribosome subunits, as well as the monosomes (80S) and polysomes are marked. B, northern blotting on fractions from sucrose gradients treated with cycloheximide reveal the distribution of 5.8S rRNA and 7S pre-rRNA. The fraction of 7S rRNA present in polysomes was quantitated as described in Experimental procedures. C, to confirm that rRNA species detected by northern blotting in polysomes are not aggregates or other large complexes, samples were treated with puromycin prior to loading on the sucrose gradient and (D) fractions from these gradients were analyzed by northern blotting as described for (B). The fraction of 7S pre-rRNA migrating in polysomes versus total 7S pre-rRNA was quantified using data from three biological replicates for samples treated with cycloheximide (E) and two independent biological replicates for lysates treated with puromycin (F). Error bars represent SEM from biological replicates. Statistical significance was calculated by Student’s t test (∗p-value <0.05).CC BY · PubMed Central
Figure 7 The pathogenic amino acid substitution in EXOSC4decreases the steady-state level of the protein andcan alter interactions with other RNA exosome subunits.A, the murine EXOSC4-L187P variant, corresponding to the human EXOSC4 variant identified in patients, is present at a lower steady-state level than WT murine EXOSC4 in a mouse neuronal cell line. Lysates of mouse N2a cells transfected with empty vector or vector expressing murine Myc-EXOSC4 or Myc-EXOSC4-L187P were analyzed by immunoblotting with anti-Myc antibody to detect Myc-EXOSC4 proteins. The stain-free signal serves as a loading control and neomycin phosphotransferase II (NPTII) serves as a transfection control. B, quantitation of the relative level of EXOSC4-L187P protein compared to EXOSC4 detected in the lysates of N2a cells expressing Myc-tagged EXOSC4 or EXOSC4-L187P from four immunoblot experiments – one shown in (A). The graph shows the relative level of EXOSC4-Myc protein compared to WT EXOSC4 (WT) from four independent experiments (n = 4). Error bars represent SEM. Statistical significance is calculated by a Student’s t test (∗∗p-value ≤ 0.01). C, Myc-EXOSC4 or Myc-EXOSC4-L187P was immunoprecipitated from N2a cells and interactions with the RNA exosome subunits EXOSC8, EXOSC9, and the RNA exosome–associated EXOSC10 were analyzed by immunoblotting. Both the input and bound samples are shown for Myc-EXOSC4 and Myc-EXOSC4-L187P. NPTII represents the neomycin phosphotransferase II, which is encoded on the Myc-EXOSC4/EXOSC4-L187P plasmids, indicating similar levels of transfection for EXOSC4 and EXOSC4-L187P. Hsp90 serves as a loading control.
Figure 7 The pathogenic amino acid substitution in EXOSC4decreases the steady-state level of the protein andcan alter interactions with other RNA exosome subunits.A, the murine EXOSC4-L187P variant, corresponding to the human EXOSC4 variant identified in patients, is present at a lower steady-state level than WT murine EXOSC4 in a mouse neuronal cell line. Lysates of mouse N2a cells transfected with empty vector or vector expressing murine Myc-EXOSC4 or Myc-EXOSC4-L187P were analyzed by immunoblotting with anti-Myc antibody to detect Myc-EXOSC4 proteins. The stain-free signal serves as a loading control and neomycin phosphotransferase II (NPTII) serves as a transfection control. B, quantitation of the relative level of EXOSC4-L187P protein compared to EXOSC4 detected in the lysates of N2a cells expressing Myc-tagged EXOSC4 or EXOSC4-L187P from four immunoblot experiments – one shown in (A). The graph shows the relative level of EXOSC4-Myc protein compared to WT EXOSC4 (WT) from four independent experiments (n = 4). Error bars represent SEM. Statistical significance is calculated by a Student’s t test (∗∗p-value ≤ 0.01). C, Myc-EXOSC4 or Myc-EXOSC4-L187P was immunoprecipitated from N2a cells and interactions with the RNA exosome subunits EXOSC8, EXOSC9, and the RNA exosome–associated EXOSC10 were analyzed by immunoblotting. Both the input and bound samples are shown for Myc-EXOSC4 and Myc-EXOSC4-L187P. NPTII represents the neomycin phosphotransferase II, which is encoded on the Myc-EXOSC4/EXOSC4-L187P plasmids, indicating similar levels of transfection for EXOSC4 and EXOSC4-L187P. Hsp90 serves as a loading control.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 1 Not valid · 25 Not checked · 101 Own results and interpretations

64 more claims

Create a free account to see all 127 claims and to verify the 41 references still open.

See all claims — free account
  • It may state two separate claims as one. 26
  • Probably not a substantial claim. 40

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Research works printed but not linked: 1

  1. Klebe R.J. Ruddle F.H. Neuroblastoma: cell culture analysis of a differentiating stem cell system J. Cell Biol. 43 1969 69a

Cited by

See all 20

Metadata

Authors
Fasken, M. B., Leung, S. W., Cureton, L. A., Al-Awadi, M., Al-Kindy, A., van Hoof, A., Khoshnevis, S., Ghalei, H., Al-Maawali, A., & Corbett, A. H.
Affiliations
  • Emory University (US)
  • Sultan Qaboos Hospital (OM)
  • The University of Texas Health Science Center at Houston (US)
  • Sultan Qaboos University Hospital (OM)
Corresponding author
  • Fasken, Milo B.
  • Ghalei, Homa
  • Al-Maawali, Almundher
  • Corbett, Anita H.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2024-08
Volume
300
Issue
8
Pages
107571
ISSN
0021-9258 (ISSN-L)
OpenAlex
W4400618295
Cited by
20
References
62
Citations by year
2026: 14 · 2025: 6
FWCI
1.90
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • medRxiv (submittedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
  • PubMed (submittedVersion)
Funders
  • Nihon Kohden America (R01GM130147, R35GM138123)
  • Sultan Qaboos University
  • Emory University
  • National Institutes of Health
  • Woodruff Health Sciences Center, Emory University
  • Sultan Qaboos Cultural Center (T32GM149422, SR/MED/GENT/16/01)
  • Office of The Provost
  • School of Medicine, Emory University
  • McMicken College of Arts and Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
RNA exosome, missense mutations, neurodevelopmental disorders, autosomal recessive disorder, RNA processing, RNA degradation, translation (biology), polysomes, basal ganglia calcification, renal failure, fetal growth restriction, developmental delay, homozygosity
MeSH terms
Alleles, Female, Humans, Male, Saccharomyces cerevisiae, Protein Biosynthesis, RNA-Binding Proteins, Mutation, Missense, Saccharomyces cerevisiae Proteins, Exosomes, Exosome Multienzyme Ribonuclease Complex, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.